Walmart to Replace Astrazeneca on Nasdaq-100 on Jan 20

Date:

MarketsA Walmart worker in a holiday costume gathers shopping carts in the parking area of a Walmart Supercenter store in Monroe, New York, U.S., December 9, 2025. Mike Segar/ReutersReuters1/11/2026|Updated: 1/11/20260:00Walmart will replace British drugmaker AstraZeneca in the Nasdaq-100 Index on January 20, the exchange operator said on Friday.The retail giant said in November it would shift its longtime listing on the New York Stock Exchange to its main rival.ReutersAuthorAuthor’s Selected ArticlesEPA to Reassess Safety of Herbicide ParaquatJan 12, 2026Bessent Says Australia, India Invited to G7 Meeting on Critical MineralsJan 11, 2026Death Toll in Philippines Landfill Collapse Rises to 4Jan 11, 2026Following Venezuela, Nicaragua Releases Prisoners After US DemandsJan 11, 2026

spot_imgspot_imgspot_img

Share post:

More like this
Related

A Guide to Finding the Best VA Mortgage Lender

Finding the right VA mortgage lender can help veterans...

Candy Makers Rethink Chocolate Amid Cocoa Market Volatility

Hershey's chocolates for sale on a store shelf in...

Federal Judge Temporarily Blocks Nexstar-Tegna Merger Amid Antitrust Lawsuit

The Tegna Inc. headquarters in Mclean, Va., on March...

US Natural Gas Exports Forecasted to Grow 28 Percent by 2027

A vessel at the Strait of Hormuz, off the...